Cargando…
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902395/ https://www.ncbi.nlm.nih.gov/pubmed/36460777 http://dx.doi.org/10.1038/s41416-022-02087-9 |
| _version_ | 1784883251977912320 |
|---|---|
| author | Dieci, Maria Vittoria Carbognin, Luisa Miglietta, Federica Canino, Fabio Giorgi, Carlo Alberto Cumerlato, Enrico Amato, Ottavia Massa, Davide Griguolo, Gaia Genovesi, Elisa Garufi, Giovanna Giannarelli, Diana Tornincasa, Antonio Trudu, Lucia Michieletto, Silvia Saibene, Tania Lo Mele, Marcello Fassan, Matteo Zarrilli, Giovanni Piacentini, Federico Bria, Emilio Guarneri, Valentina |
| author_facet | Dieci, Maria Vittoria Carbognin, Luisa Miglietta, Federica Canino, Fabio Giorgi, Carlo Alberto Cumerlato, Enrico Amato, Ottavia Massa, Davide Griguolo, Gaia Genovesi, Elisa Garufi, Giovanna Giannarelli, Diana Tornincasa, Antonio Trudu, Lucia Michieletto, Silvia Saibene, Tania Lo Mele, Marcello Fassan, Matteo Zarrilli, Giovanni Piacentini, Federico Bria, Emilio Guarneri, Valentina |
| author_sort | Dieci, Maria Vittoria |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9902395 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99023952023-02-08 Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation Dieci, Maria Vittoria Carbognin, Luisa Miglietta, Federica Canino, Fabio Giorgi, Carlo Alberto Cumerlato, Enrico Amato, Ottavia Massa, Davide Griguolo, Gaia Genovesi, Elisa Garufi, Giovanna Giannarelli, Diana Tornincasa, Antonio Trudu, Lucia Michieletto, Silvia Saibene, Tania Lo Mele, Marcello Fassan, Matteo Zarrilli, Giovanni Piacentini, Federico Bria, Emilio Guarneri, Valentina Br J Cancer Correction Nature Publishing Group UK 2022-12-02 2023-01-19 /pmc/articles/PMC9902395/ /pubmed/36460777 http://dx.doi.org/10.1038/s41416-022-02087-9 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Dieci, Maria Vittoria Carbognin, Luisa Miglietta, Federica Canino, Fabio Giorgi, Carlo Alberto Cumerlato, Enrico Amato, Ottavia Massa, Davide Griguolo, Gaia Genovesi, Elisa Garufi, Giovanna Giannarelli, Diana Tornincasa, Antonio Trudu, Lucia Michieletto, Silvia Saibene, Tania Lo Mele, Marcello Fassan, Matteo Zarrilli, Giovanni Piacentini, Federico Bria, Emilio Guarneri, Valentina Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation |
| title | Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation |
| title_full | Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation |
| title_fullStr | Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation |
| title_full_unstemmed | Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation |
| title_short | Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation |
| title_sort | correction: incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and til evaluation |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902395/ https://www.ncbi.nlm.nih.gov/pubmed/36460777 http://dx.doi.org/10.1038/s41416-022-02087-9 |
| work_keys_str_mv | AT diecimariavittoria correctionincorporatingweeklycarboplatininanthracyclineandpaclitaxelcontainingneoadjuvantchemotherapyfortriplenegativebreastcancerpropensityscorematchinganalysisandtilevaluation AT carbogninluisa correctionincorporatingweeklycarboplatininanthracyclineandpaclitaxelcontainingneoadjuvantchemotherapyfortriplenegativebreastcancerpropensityscorematchinganalysisandtilevaluation AT migliettafederica correctionincorporatingweeklycarboplatininanthracyclineandpaclitaxelcontainingneoadjuvantchemotherapyfortriplenegativebreastcancerpropensityscorematchinganalysisandtilevaluation AT caninofabio correctionincorporatingweeklycarboplatininanthracyclineandpaclitaxelcontainingneoadjuvantchemotherapyfortriplenegativebreastcancerpropensityscorematchinganalysisandtilevaluation AT giorgicarloalberto correctionincorporatingweeklycarboplatininanthracyclineandpaclitaxelcontainingneoadjuvantchemotherapyfortriplenegativebreastcancerpropensityscorematchinganalysisandtilevaluation AT cumerlatoenrico correctionincorporatingweeklycarboplatininanthracyclineandpaclitaxelcontainingneoadjuvantchemotherapyfortriplenegativebreastcancerpropensityscorematchinganalysisandtilevaluation AT amatoottavia correctionincorporatingweeklycarboplatininanthracyclineandpaclitaxelcontainingneoadjuvantchemotherapyfortriplenegativebreastcancerpropensityscorematchinganalysisandtilevaluation AT massadavide correctionincorporatingweeklycarboplatininanthracyclineandpaclitaxelcontainingneoadjuvantchemotherapyfortriplenegativebreastcancerpropensityscorematchinganalysisandtilevaluation AT griguologaia correctionincorporatingweeklycarboplatininanthracyclineandpaclitaxelcontainingneoadjuvantchemotherapyfortriplenegativebreastcancerpropensityscorematchinganalysisandtilevaluation AT genovesielisa correctionincorporatingweeklycarboplatininanthracyclineandpaclitaxelcontainingneoadjuvantchemotherapyfortriplenegativebreastcancerpropensityscorematchinganalysisandtilevaluation AT garufigiovanna correctionincorporatingweeklycarboplatininanthracyclineandpaclitaxelcontainingneoadjuvantchemotherapyfortriplenegativebreastcancerpropensityscorematchinganalysisandtilevaluation AT giannarellidiana correctionincorporatingweeklycarboplatininanthracyclineandpaclitaxelcontainingneoadjuvantchemotherapyfortriplenegativebreastcancerpropensityscorematchinganalysisandtilevaluation AT tornincasaantonio correctionincorporatingweeklycarboplatininanthracyclineandpaclitaxelcontainingneoadjuvantchemotherapyfortriplenegativebreastcancerpropensityscorematchinganalysisandtilevaluation AT trudulucia correctionincorporatingweeklycarboplatininanthracyclineandpaclitaxelcontainingneoadjuvantchemotherapyfortriplenegativebreastcancerpropensityscorematchinganalysisandtilevaluation AT michielettosilvia correctionincorporatingweeklycarboplatininanthracyclineandpaclitaxelcontainingneoadjuvantchemotherapyfortriplenegativebreastcancerpropensityscorematchinganalysisandtilevaluation AT saibenetania correctionincorporatingweeklycarboplatininanthracyclineandpaclitaxelcontainingneoadjuvantchemotherapyfortriplenegativebreastcancerpropensityscorematchinganalysisandtilevaluation AT lomelemarcello correctionincorporatingweeklycarboplatininanthracyclineandpaclitaxelcontainingneoadjuvantchemotherapyfortriplenegativebreastcancerpropensityscorematchinganalysisandtilevaluation AT fassanmatteo correctionincorporatingweeklycarboplatininanthracyclineandpaclitaxelcontainingneoadjuvantchemotherapyfortriplenegativebreastcancerpropensityscorematchinganalysisandtilevaluation AT zarrilligiovanni correctionincorporatingweeklycarboplatininanthracyclineandpaclitaxelcontainingneoadjuvantchemotherapyfortriplenegativebreastcancerpropensityscorematchinganalysisandtilevaluation AT piacentinifederico correctionincorporatingweeklycarboplatininanthracyclineandpaclitaxelcontainingneoadjuvantchemotherapyfortriplenegativebreastcancerpropensityscorematchinganalysisandtilevaluation AT briaemilio correctionincorporatingweeklycarboplatininanthracyclineandpaclitaxelcontainingneoadjuvantchemotherapyfortriplenegativebreastcancerpropensityscorematchinganalysisandtilevaluation AT guarnerivalentina correctionincorporatingweeklycarboplatininanthracyclineandpaclitaxelcontainingneoadjuvantchemotherapyfortriplenegativebreastcancerpropensityscorematchinganalysisandtilevaluation |